Ventfort plus Chonsurid: dental bone-healing method — RU2593817C2
Андрей Константинович Иорданишвили, Антон Анатольевич Сериков, Дмитрий Викторович Балин, Анна Геннадьевна Слугина, Владимир Владимирович Самсонов, Борис Лаврович Макеев, Ирина Борисовна Долгова · 2016 · RU2593817C2 · patent family 56011738
Published 2016-08-10.
Reported patent results
Reported findings
The Ventfort case had higher final density but slightly later reported healing, alongside a larger defect.
Two dental-cyst examples with Chonsurid; one also received branded Ventfort before surgery.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Ventfort adjunct case | 22 mm defect: healing at 6.5 months; density 211 HU | One 63-year-old patient |
| Chonsurid-only example | 14 mm defect: healing at 6 months; density 194 HU | One 64-year-old patient |
| Neutral timing observation | Longer intake reportedly did not further accelerate healing; postoperative or shorter preoperative use lacked a marked benefit | No group sizes or effect estimates supplied |
These selected cases do not establish faster healing. Defect size, different patients, co-treatment and extract identity prevent attribution to Ventfort or a defined vascular peptide.
Source for the extracted data ↗ · Checked 2026-11-06
Patent claims and provenance
Use. The patent describes branded Ventfort in a combined dental-treatment approach.
The extract brand is not interchangeable with Vasolin, Slavinorm or purified KED, and combined treatment prevents independent attribution.
- Publication
- RU2593817C2 ↗ · 2016-08-10
- Earliest priority / filing
- 2014-10-20 / 2014-10-20
- Original applicant / assignee
- Андрей Константинович Иорданишвили
- Indexed status
- Not shown; official status unverified · checked 2026-11-06
- Patent family
- 56011738 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Method of accelerating process of reparative osteogenesis
Inventors: Андрей Константинович Иорданишвили; Антон Анатольевич Сериков; Дмитрий Викторович Балин; Анна Геннадьевна Слугина; Владимир Владимирович Самсонов; Борис Лаврович Макеев; Ирина Борисовна Долгова.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- The extract brand is not interchangeable with Vasolin, Slavinorm or purified KED, and combined treatment prevents independent attribution.
- These selected cases do not establish faster healing. Defect size, different patients, co-treatment and extract identity prevent attribution to Ventfort or a defined vascular peptide.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original patent text and indexed metadata
Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related-report group: patent-family-56011738. Reports in this group are not assumed to be independent trials.
Source access and review scope
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Patent publication
Citation and original source
Original source: Андрей Константинович Иорданишвили, Антон Анатольевич Сериков, Дмитрий Викторович Балин, Анна Геннадьевна Слугина, Владимир Владимирович Самсонов, Борис Лаврович Макеев, Ирина Борисовна Долгова. Ventfort plus Chonsurid: dental bone-healing method — RU2593817C2 RU2593817C2 · patent family 56011738 2016.
Molekul research summary: https://molekul.io/research/patent-ru2593817c2. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry